Literature DB >> 11305382

An open study of efficacy and safety of long-term treatment with mometasone furoate fatty cream in the treatment of adult patients with atopic dermatitis.

J Faergemann1, O Christensen, P Sjövall, A Johnsson, K Hersle, P Nordin, B Edmar, A Svensson.   

Abstract

BACKGROUND: Atopic dermatitis is a severe chronic skin disease often deteriorated by the presence of microorganisms and often responds well to treatment with potent corticosteroids. However, the long-term use of potent topical corticosteroids are accompanied by side-effects such as skin atrophy.
OBJECTIVE: To study the effect and safety of prophylactic treatment with mometasone furoate fatty cream (contains hexylene glycol) for 6 months in patients with atopic dermatitis.
RESULTS: Sixty-one of 68 (90%) patients were still free of their disease after 6 months of twice weekly treatment and only one showed possible treatment related signs of skin atrophy. The number of Staphylococcus aureus and Pityrosporum ovale were significantly reduced in cleared patients.
CONCLUSIONS: Mometasone furoate fatty cream is effective and safe both for treatment and as a prophylaxis in patients with atopic dermatitis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11305382     DOI: 10.1046/j.1468-3083.2000.00099.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  3 in total

1.  A low level of health literacy is a predictor of corticophobia in atopic dermatitis.

Authors:  Tiago Fernandes Gomes; Katarina Kieselova; Victoria Guiote; Martinha Henrique; Felicidade Santiago
Journal:  An Bras Dermatol       Date:  2022-08-31       Impact factor: 2.113

2.  The Clinical Efficacy of Mometasone Furoate in Multi-Lamellar Emulsion for Eczema: A Double-blinded Crossover Study.

Authors:  Duk Han Kim; Hyun Jong Lee; Chun Wook Park; Kyu Han Kim; Kwang Hoon Lee; Byung In Ro; Sang Hyun Cho
Journal:  Ann Dermatol       Date:  2013-02-14       Impact factor: 1.444

Review 3.  Comparative safety and efficacy of topical mometasone furoate with other topical corticosteroids.

Authors:  Fabrizio Spada; Tanya M Barnes; Kerryn A Greive
Journal:  Australas J Dermatol       Date:  2018-02-07       Impact factor: 2.875

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.